Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation

被引:10
|
作者
Haciislamoglu, Emel [1 ]
Gungor, Gorkem [2 ]
Aydin, Gokhan [2 ]
Canyilmaz, Emine [1 ]
Guler, Ozan Cem [3 ]
Zengin, Ahmet Yasar [4 ]
Yenice, Kamil Mehmet [5 ]
机构
[1] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkey
[2] Acibadem Univ, Dept Radiat Oncol, Istanbul, Turkey
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana, Turkey
[4] Kanuni Res & Educ Hosp, Dept Radiat Oncol, Trabzon, Turkey
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
来源
关键词
flattening filter free (FFF); prostate cancer; radiation-induced secondary cancer; radiotherapy (RT); volumetric modulated arc therapy (VMAT); INTENSITY-MODULATED RADIOTHERAPY; ATOMIC-BOMB SURVIVORS; RADIATION-INDUCED CANCER; OF-FIELD PHOTON; CALCULATED RISK; SOLID CANCER; ARC THERAPY; FLATTENING FILTER; 2ND CANCERS; EXPOSURE;
D O I
10.1002/acm2.12972
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We aimed to estimate the risk of secondary cancer after radiotherapy (RT) in high-risk prostate cancer (HRPC) patients with pelvic irradiation. Computed tomography data of five biopsy-proven HRPC patients were selected for this study. Two different planning target volumes (PTV(1)and PTV2) were contoured for each patient. The PTV(1)included the prostate, seminal vesicles, and pelvic lymphatics, while the PTV(2)included only the prostate and seminal vesicles. The prescribed dose was 54 Gy for the PTV(1)with a sequential boost (24 Gy for the PTV2). Intensity-modulated RT (IMRT) and volumetric modulated arc therapy (VMAT) techniques were used to generate treatment plans with 6 and 10 MV photon energies with the flattening filter (FF) or flattening filter-free (FFF) irradiation mode. The excess absolute risks (EARs) were calculated and compared for the bladder, rectum, pelvic bone, and soft tissue based on the linear-exponential, plateau, full mechanistic, and specific mechanistic sarcoma dose-response model. According to the models, all treatment plans resulted in similar risks of secondary bladder or rectal cancer and pelvic bone or soft tissue sarcoma except for the estimated risk of the bladder according to the full mechanistic model using IMRT((6MV;FF))technique compared with VMAT techniques with FFF options. The overall estimation of EAR indicated that the radiation-induced cancer risk due to RT in HRPC was lower for bladder than the rectum. EAR values ranged from 1.47 to 5.82 for bladder and 6.36 to 7.94 for rectum, depending on the dose-response models used. The absolute risks of the secondary pelvic bone and soft tissue sarcoma were small for the plans examined. We theoretically predicted the radiation-induced secondary cancer risk in HRPC patients with pelvic irradiation. Nevertheless, prospective clinical trials, with larger patient cohorts with a long-term follow-up, are needed to validate these model predictions.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 50 条
  • [21] Is surgery superior to radiotherapy for high-risk prostate cancer?
    Eastham, James A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 438 - 438
  • [22] Improving outcomes in high-risk prostate cancer with radiotherapy
    Polkinghorn, William R.
    Zelefsky, Michael J.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (06) : 333 - 337
  • [23] Impact of pelvic irradiation on fiducial tracking prior to SBRT for high-risk prostate cancer
    Lischalk, J.
    Santos, V. F.
    Coakley, M.
    Akerman, M.
    Sanchez, A.
    Mendez, C.
    Carpenter, T.
    Katz, A.
    Corcoran, A.
    Marans, H. Y.
    Clancey, O.
    Witten, M.
    Taneja, S. S.
    Haas, J. A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1177 - S1178
  • [24] Acute toxicity in patients with high-risk prostate cancer treated with stereotactic body radiation, with irradiation to the prostate and pelvic nodes
    Faria, S.
    Duclos, M.
    Cury, F.
    Patrocinio, H.
    Souhami, L.
    CANCER RADIOTHERAPIE, 2024, 28 (02): : 159 - 163
  • [25] Radiotherapy for high-risk patients after radical prostatectomy for prostate cancer: Immediate postoperative or salvage?
    Pasquier, D.
    Kouto, H.
    Ballereau, C.
    PROGRES EN UROLOGIE, 2009, 19 (07): : 447 - 456
  • [26] Pelvic lymph node recurrence in high-risk prostate cancer following prostate-only radiotherapy
    Hussain, Sameed
    Wajid, Muhammad Imran
    Omer, Muhammad
    Khan, Muhammad Yousuf
    Maqsood, Talha
    Zeb, Adnan
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2021, 22
  • [27] Radiotherapy in high risk prostate cancer: Whole pelvic radiotherapy vs prostate only radiotherapy
    Hernandez, A.
    Pelari, L.
    Caddedu, G.
    Ciscar, I.
    Ytuza, K.
    Sastre, S.
    Carrasco, E.
    Lopez, F.
    Vallejo, C.
    Sancho, S.
    Hervas, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S614 - S615
  • [28] A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
    Novikov, Sergey Nikolaevich
    Novikov, Roman Vladimirovich
    Merezhko, Yurii Olegovich
    Gotovchikova, Mariya Yurevna
    Ilin, Nikolai Dmitrievich
    Melnik, Yulia Sergeevna
    Kanaev, Sergey Vasilevich
    RADIATION ONCOLOGY JOURNAL, 2022, 40 (03): : 200 - 207
  • [29] PELVIC NODAL RADIOTHERAPY IN PATIENTS WITH UNFAVORABLE INTERMEDIATE AND HIGH-RISK PROSTATE CANCER: EVIDENCE, RATIONALE, AND FUTURE DIRECTIONS
    Morikawa, Lisa K.
    Roach, Mack, III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 6 - 16
  • [30] Acute toxicity after SABR to the prostate and pelvic lymph nodes for high-risk prostate cancer
    Fredman, Elisha T.
    Shemesh, Danielle
    Limon, Dror
    Moore, Assaf
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2477 - S2477